CMS Increases Final Pricing Determination for Oncotype DX Breast Cancer Test to Previously Established Rate of $3,416
October 07, 2015 at 08:09 AM EDT
On Tuesday, October 6, 2015, the Centers for Medicare and Medicaid Services (CMS), which administers the Medicare program, issued ...
